Reardon Andrew — SEC Form 4 filings
SEC reporting owner CIK 1950232. 22 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2024-02-16 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 60 legs across 13 filings — 50,500 shares, $10,179,181 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 43.
- Largest priced transaction: sale of 10,000 shares @ $83.04 ($830,449) in LIGAND PHARMACEUTICALS INC, filed 2024-05-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | 22 | — | 60 legs · 50,500 sh · $10,179,181 | 43 |
Form 4 filings — Reardon Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Sale (S): 300 @ $283.99 · Sale (S): 1,800 @ $285.17 · Sale (S): 2,115 @ $286.36 · Sale (S): 385 @ $287.53 · Sale (S): 400 @ $288.98 | EDGAR |
| 2026-08-04 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 5,000 @ $52.27 · Sale (S): 105 @ $284.14 · Sale (S): 33 @ $284.55 · Sale (S): 157 @ $285.74 · Sale (S): 1,032 @ $286.80 · Sale (S): 1,214 @ $287.77 · +6 more | EDGAR |
| 2026-07-06 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Other (J): 132 @ $160.71 · Option exercise (M): 5,000 @ $52.27 · Sale (S): 396 @ $308.99 · Sale (S): 104 @ $310.20 · Sale (S): 1,119 @ $311.72 · Sale (S): 1,081 @ $312.28 · +5 more | EDGAR |
| 2026-06-02 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 5,000 @ $52.27 · Sale (S): 491 @ $223.95 · Sale (S): 677 @ $225.20 · Sale (S): 1,432 @ $225.97 · Sale (S): 400 @ $226.78 · Sale (S): 584 @ $228.57 · +3 more | EDGAR |
| 2026-05-04 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 5,000 @ $52.27 · Sale (S): 600 @ $227.45 · Sale (S): 932 @ $228.75 · Sale (S): 98 @ $229.71 · Sale (S): 370 @ $230.87 · Sale (S): 780 @ $232.04 · +3 more | EDGAR |
| 2026-04-02 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 5,000 @ $52.27 · Sale (S): 460 @ $198.85 · Sale (S): 1,302 @ $199.72 · Sale (S): 1,238 @ $200.94 · Sale (S): 700 @ $201.90 · Sale (S): 963 @ $203.22 · +2 more | EDGAR |
| 2026-03-27 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 4,513 @ $0 · Grant/award (A): 21,525 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 5,000 @ $52.27 · Sale (S): 100 @ $197.70 · Sale (S): 100 @ $199.00 · Sale (S): 207 @ $199.96 · Sale (S): 93 @ $200.62 · Sale (S): 300 @ $201.70 · +7 more | EDGAR |
| 2026-02-18 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 6,928 @ $0 · Tax withholding (F): 3,211 @ $183.83 · Grant/award (A): 8,810 @ $0 · Tax withholding (F): 4,083 @ $183.83 · Tax withholding (F): 593 @ $183.83 · Tax withholding (F): 801 @ $183.83 · +1 more | EDGAR |
| 2025-08-12 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Tax withholding (F): 1,325 @ $150.06 | EDGAR |
| 2025-07-02 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Other (J): 233 @ $91.08 | EDGAR |
| 2025-06-24 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Sale (S): 500 @ $114.08 | EDGAR |
| 2025-06-12 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Sale (S): 500 @ $114.54 | EDGAR |
| 2025-06-02 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Tax withholding (F): 897 @ $100.16 · Sale (S): 1,000 @ $104 | EDGAR |
| 2025-03-06 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 6,415 @ $0 · Grant/award (A): 28,043 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 6,928 @ $0 · Tax withholding (F): 2,775 @ $120 · Grant/award (A): 5,429 @ $0 · Tax withholding (F): 1,758 @ $120 · Tax withholding (F): 1,114 @ $120 · Tax withholding (F): 876 @ $120 | EDGAR |
| 2024-09-25 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,000 @ $52.27 · Sale (S): 2,000 @ $99.60 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 1,500 @ $52.27 · Sale (S): 1,500 @ $106.39 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Other (J): 329 @ $60.71 | EDGAR |
| 2024-05-13 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 10,000 @ $52.27 · Sale (S): 10,000 @ $83.04 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 7,208 @ $0 · Grant/award (A): 29,272 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Tax withholding (F): 593 @ $74.65 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1950232 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →